NDC properties for "Combigan (brimonidine tartrate 0.2 % / timolol 0.5 % ) Ophthalmic Solution" (RxCUI 861637)
About this data
The tables show NDC propoerties for Combigan (brimonidine tartrate 0.2 % / timolol 0.5 % ) Ophthalmic Solution with the RxCUI 861637
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Combigan (brimonidine tartrate 0.2 % / timolol 0.5 % ) Ophthalmic Solution (RxCUI 861637)
| MMSL_CODE | BD12362 |
|---|---|
| NDA | NDA021398 |
| RxCUI | 861637 |
| SPL_SET_ID | 8c641b6c-3335-4ec3-89b9-2d97a8901062 |
| SPL_SET_ID | feaf1480-a4b8-4486-992a-96be3a596243 |
| Prescribable Synonym | Combigan 0.2 % / 0.5 % Ophthalmic Solution |
| RXNAV_STR | Combigan (brimonidine tartrate 0.2 % / timolol 0.5 % ) Ophthalmic Solution |
| RxNorm Name | brimonidine tartrate 2 MG/ML / timolol 5 MG/ML Ophthalmic Solution [Combigan] |
| RxNorm Synonym | Combigan (brimonidine tartrate 0.2 % / timolol 0.5 % ) Ophthalmic Solution |
| Related queries | Interactions (for RxCUI 861637) |
NDC Properties
NDC Item 00023921103
| NDC 9 | 0023-9211 |
|---|---|
| NDC 10 | 0023-9211-03 |
| NDC Item | 00023921103 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (0023-9211-03) / 2.5 mL in 1 BOTTLE, DROPPER |
| Labeler | Allergan, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2007-11-14 |
| Marketing status | ACTIVE |
| NDA | NDA021398 |
| Related queries | Properties for NDC 9 0023-9211 |
NDC Item 00023921105
| NDC 9 | 0023-9211 |
|---|---|
| NDC 10 | 0023-9211-05 |
| NDC Item | 00023921105 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (0023-9211-05) / 5 mL in 1 BOTTLE, DROPPER |
| Labeler | Allergan, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2007-11-14 |
| Marketing status | ACTIVE |
| NDA | NDA021398 |
| Related queries | Properties for NDC 9 0023-9211 |
NDC Item 00023921110
| NDC 9 | 0023-9211 |
|---|---|
| NDC 10 | 0023-9211-10 |
| NDC Item | 00023921110 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (0023-9211-10) / 10 mL in 1 BOTTLE, DROPPER |
| Labeler | Allergan, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2007-11-14 |
| Marketing status | ACTIVE |
| NDA | NDA021398 |
| Related queries | Properties for NDC 9 0023-9211 |
NDC Item 00023921115
| NDC 9 | 0023-9211 |
|---|---|
| NDC 10 | 0023-9211-15 |
| NDC Item | 00023921115 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (0023-9211-15) / 15 mL in 1 BOTTLE, DROPPER |
| Labeler | Allergan, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2007-11-14 |
| Marketing status | ACTIVE |
| NDA | NDA021398 |
| Related queries | Properties for NDC 9 0023-9211 |
NDC Item 00023921103
| NDC 9 | 0023-9211 |
|---|---|
| NDC 10 | 0023-9211-03 |
| NDC Item | 00023921103 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (0023-9211-03) / 2.5 mL in 1 BOTTLE, DROPPER |
| Labeler | Allergan, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2007-11-14 |
| Marketing status | ACTIVE |
| NDA | NDA021398 |
| Related queries | Properties for NDC 9 0023-9211 |
NDC Item 00023921105
| NDC 9 | 0023-9211 |
|---|---|
| NDC 10 | 0023-9211-05 |
| NDC Item | 00023921105 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (0023-9211-05) / 5 mL in 1 BOTTLE, DROPPER |
| Labeler | Allergan, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2007-11-14 |
| Marketing status | ACTIVE |
| NDA | NDA021398 |
| Related queries | Properties for NDC 9 0023-9211 |
NDC Item 00023921110
| NDC 9 | 0023-9211 |
|---|---|
| NDC 10 | 0023-9211-10 |
| NDC Item | 00023921110 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (0023-9211-10) / 10 mL in 1 BOTTLE, DROPPER |
| Labeler | Allergan, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2007-11-14 |
| Marketing status | ACTIVE |
| NDA | NDA021398 |
| Related queries | Properties for NDC 9 0023-9211 |
NDC Item 00023921115
| NDC 9 | 0023-9211 |
|---|---|
| NDC 10 | 0023-9211-15 |
| NDC Item | 00023921115 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (0023-9211-15) / 15 mL in 1 BOTTLE, DROPPER |
| Labeler | Allergan, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2007-11-14 |
| Marketing status | ACTIVE |
| NDA | NDA021398 |
| Related queries | Properties for NDC 9 0023-9211 |
NDC Item 00023921103
| NDC 9 | 0023-9211 |
|---|---|
| NDC 10 | 0023-9211-03 |
| NDC Item | 00023921103 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (0023-9211-03) / 2.5 mL in 1 BOTTLE, DROPPER |
| Labeler | Allergan, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2007-11-14 |
| Marketing status | ACTIVE |
| NDA | NDA021398 |
| Related queries | Properties for NDC 9 0023-9211 |
NDC Item 00023921105
| NDC 9 | 0023-9211 |
|---|---|
| NDC 10 | 0023-9211-05 |
| NDC Item | 00023921105 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (0023-9211-05) / 5 mL in 1 BOTTLE, DROPPER |
| Labeler | Allergan, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2007-11-14 |
| Marketing status | ACTIVE |
| NDA | NDA021398 |
| Related queries | Properties for NDC 9 0023-9211 |
NDC Item 00023921110
| NDC 9 | 0023-9211 |
|---|---|
| NDC 10 | 0023-9211-10 |
| NDC Item | 00023921110 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (0023-9211-10) / 10 mL in 1 BOTTLE, DROPPER |
| Labeler | Allergan, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2007-11-14 |
| Marketing status | ACTIVE |
| NDA | NDA021398 |
| Related queries | Properties for NDC 9 0023-9211 |
NDC Item 00023921115
| NDC 9 | 0023-9211 |
|---|---|
| NDC 10 | 0023-9211-15 |
| NDC Item | 00023921115 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (0023-9211-15) / 15 mL in 1 BOTTLE, DROPPER |
| Labeler | Allergan, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2007-11-14 |
| Marketing status | ACTIVE |
| NDA | NDA021398 |
| Related queries | Properties for NDC 9 0023-9211 |
NDC Item 00023921103
| NDC 9 | 0023-9211 |
|---|---|
| NDC 10 | 0023-9211-03 |
| NDC Item | 00023921103 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (0023-9211-03) / 2.5 mL in 1 BOTTLE, DROPPER |
| Labeler | Allergan, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2007-11-14 |
| Marketing status | ACTIVE |
| NDA | NDA021398 |
| Related queries | Properties for NDC 9 0023-9211 |
NDC Item 00023921105
| NDC 9 | 0023-9211 |
|---|---|
| NDC 10 | 0023-9211-05 |
| NDC Item | 00023921105 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (0023-9211-05) / 5 mL in 1 BOTTLE, DROPPER |
| Labeler | Allergan, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2007-11-14 |
| Marketing status | ACTIVE |
| NDA | NDA021398 |
| Related queries | Properties for NDC 9 0023-9211 |
NDC Item 00023921110
| NDC 9 | 0023-9211 |
|---|---|
| NDC 10 | 0023-9211-10 |
| NDC Item | 00023921110 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (0023-9211-10) / 10 mL in 1 BOTTLE, DROPPER |
| Labeler | Allergan, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2007-11-14 |
| Marketing status | ACTIVE |
| NDA | NDA021398 |
| Related queries | Properties for NDC 9 0023-9211 |
NDC Item 00023921115
| NDC 9 | 0023-9211 |
|---|---|
| NDC 10 | 0023-9211-15 |
| NDC Item | 00023921115 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (0023-9211-15) / 15 mL in 1 BOTTLE, DROPPER |
| Labeler | Allergan, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2007-11-14 |
| Marketing status | ACTIVE |
| NDA | NDA021398 |
| Related queries | Properties for NDC 9 0023-9211 |